Clinical Trials · NCT07012837
Transfusion Reduction in High-Bleeding-Risk Cardiac Surgery With Desmopressin
- Phase
- Phase 3
- Recruitment status
- Not Yet Recruiting
- Sponsor
- Imam Abdulrahman Bin Faisal University
- Enrollment
- 112
- Start date
- Jul 2025
- Locations
- 1 site, Saudi Arabia
- Primary endpoint
- Cumulative 48-hour postoperative bleeding